Race and hormone receptor-positive breast cancer outcomes in a randomized chemotherapy trial
about
Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studiesRacial/ethnic differences in breast cancer survival by inflammatory status and hormonal receptor status: an analysis of the Surveillance, Epidemiology, and End Results data.Long-term survivor characteristics in HER2-positive metastatic breast cancer from registHER.Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.Mortality risk of black women and white women with invasive breast cancer by hormone receptors, HER2, and p53 statusAggressive estrogen-receptor-positive breast cancer arising in patients with elevated body mass index.Ethnic and geographic variations in corpus uteri cancer burden: evidence based on data from 29 states and the District of Columbia. CI5 IX, X and SEER data (1998-2010).Race, response to chemotherapy, and outcome within clinical breast cancer subtypes.Racial and Ethnic Differences in Breast Cancer Survival: Mediating Effect of Tumor Characteristics and Sociodemographic and Treatment FactorsLong-Term Follow-Up of the E1199 Phase III Trial Evaluating the Role of Taxane and Schedule in Operable Breast Cancer.Racial differences in outcomes of triple-negative breast cancerImpact of breast cancer subtypes and treatment on survival: an analysis spanning two decades.Her2 positivity and race predict higher mastectomy rates: a SEER database analysis.Patterns and predictors of breast cancer chemotherapy use in Kaiser Permanente Northern California, 2004-2007.African American Race is an Independent Risk Factor in Survival from Initially Diagnosed Localized Breast Cancer.Racial disparities in treatment patterns and clinical outcomes in patients with HER2-positive metastatic breast cancer.Obesity and survival in operable breast cancer patients treated with adjuvant anthracyclines and taxanes according to pathological subtypes: a pooled analysisEngineered dendritic cells for gastrointestinal tumor immunotherapy: opportunities in translational research.Systemic therapy for patients with advanced human epidermal growth factor receptor 2-positive breast cancer: American Society of Clinical Oncology clinical practice guideline.Racial disparity in survival from estrogen and progesterone receptor-positive breast cancer: implications for reducing breast cancer mortality disparities.Risk of Recurrence and Mortality in a Multi-Ethnic Breast Cancer Population.Differences in the mutational landscape of triple-negative breast cancer in African Americans and Caucasians.African American patients with breast cancer have worse prognosis than white patients in certain subtypes and stages.Association of race and socioeconomic status and outcomes of patients with rectal cancer.Is the TNM staging system for breast cancer still relevant in the era of biomarkers and emerging personalized medicine for breast cancer - an institution's 10-year experience.Breast cancer survival by molecular subtype: a population-based analysis of cancer registry data.Genomic profiling of breast cancer in African-American women using MammaPrint.The effect of age on race-related breast cancer survival disparities.Estrogen receptor quantitative measures and breast cancer survival.Breast cancer survival, survival disparities, and guideline-based treatment.Prognostic value of breast cancer subtypes, Ki-67 proliferation index, age, and pathologic tumor characteristics on breast cancer survival in Caucasian women.
P2860
Q27014939-2E65DEBF-65BB-4796-B970-6E985E56D1F9Q30823443-34F2EEBF-6DAA-4DAF-AD4F-C467508B19E1Q33682910-7CDF695C-97B1-4CF2-9DED-7D6C4131F41BQ33862786-C77F2F26-3176-48E5-9345-4CF285D34D7DQ34705321-3DE4206D-E626-4029-AFD5-B0080FA98B82Q35186057-5246A00A-53D8-4CC9-9548-94FC4CB5C6A6Q35200540-8EE159AC-CB45-4527-B4CE-265D031C7FD4Q35568229-F65C83EA-ABAF-4ECF-A6F6-8B237F8B9AB3Q35801283-8A6071EE-E30B-4ECD-845F-AC80E36D4B33Q35847450-7DAA3DAC-8D49-46FE-A342-A77A03FEE7B0Q35956986-ABE9685A-0B50-48F7-8388-00C28D1375AEQ36306315-18A670B0-074D-4516-A45B-814F90787E6AQ36308052-3E72BE07-DCAD-4A3F-9E1F-14A10E9CD76FQ37161492-9B87F19D-5492-48D3-B725-67C3A4E61137Q37290523-F2AB80E5-CE75-4DF9-B854-1B5AD57A1C2EQ37298732-6D2BA690-E929-4E7B-B880-3553FA655733Q37690278-16916644-8F8F-45D5-B689-9E6486AC895BQ38051671-452DEC51-6379-4430-BABC-FDCD65A7F1FFQ38209628-4524F570-A515-4F00-9DF0-45A766871F4BQ38934402-FC524B11-936D-4807-8FB6-04781397E79BQ39076044-54901C6D-D3C0-460C-AE56-7D384CCC0B53Q39132868-7BD93FE2-3A5F-4038-81D3-61B9B3329599Q40063848-DF49A322-6DC2-4C89-A317-B69E23A8F17CQ40086705-DD8453E1-B06D-42C0-BFDA-67F9D4531BD7Q41562136-B7E37D5E-21B4-49CA-98E8-A9997A465887Q42367695-BE11568A-E8EE-4389-885D-ACFB6752E7A7Q42498238-E5953ED8-0230-41F0-BC97-DBCCC4DE39A0Q43463570-3073D3B6-9336-4092-AE79-94C5FDE52BA9Q47928157-CBAFFBCA-EB1B-4FDD-98C4-1288D8009FFBQ52641223-68F871C3-EBEE-4ECA-9723-503E891E0BCAQ53119241-C27AA536-820B-428C-A099-6D76DD9A96C7
P2860
Race and hormone receptor-positive breast cancer outcomes in a randomized chemotherapy trial
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Race and hormone receptor-posi ...... randomized chemotherapy trial
@ast
Race and hormone receptor-posi ...... randomized chemotherapy trial
@en
type
label
Race and hormone receptor-posi ...... randomized chemotherapy trial
@ast
Race and hormone receptor-posi ...... randomized chemotherapy trial
@en
prefLabel
Race and hormone receptor-posi ...... randomized chemotherapy trial
@ast
Race and hormone receptor-posi ...... randomized chemotherapy trial
@en
P2093
P2860
P356
P1476
Race and hormone receptor-posi ...... randomized chemotherapy trial
@en
P2093
Antonio C Wolff
Edith A Perez
Fengmin Zhao
George W Sledge
Jennifer A Ligibel
Joseph A Sparano
Molin Wang
Nancy E Davidson
Silvana Martino
Tom Saphner
P2860
P304
P356
10.1093/JNCI/DJR543
P407
P577
2012-01-16T00:00:00Z